Introduction: PCOS is a hormonal disorder with missed or irregular periods at the reproductive ages of women, which was mainly due to increased androgen levels. Objective: To evaluate the antiandrogen activity of EEBL (ethanolic extract of betel leaf) in DHEA induced PCOS (polycystic ovary syndrome) and improving ovulation rate, consequently its effects on hormonal and biochemical profile of the blood serum and Histopathology of the ovary. Methods: Divide the 30 immature (4-week-old) female Sprague Dawley rats into 5 groups. Four groups except the control group were injected each morning with dehydroepiandrosterone (DHEA) (6 mg/100 g body weight/0.2 ml sesame oil) for 20days. The control group was injected with 0.2ml sesame oil for 20days. Pretreatment completed after 21 st day then animals are subjected to posttreatment with EEBL (LD-100, HD-200mg/kg, p.o) and CC (100 μg/kg, p.o) from 21 to 41 days. After the treatment animals are subjected to biochemical, hormonal and histopathological examinations. Results: In negative control group SOD, Catalase were decreased. Total protein, SGOT, SGPT, TG, LDL and cholesterol levels were increased than the control group. Hormones LH and Testosterone levels increased. FSH, estradiol, and progesterone levels were decreased when compared with the control group. Histopathology has revealed that the presence of cysts in the negative control group and recovery of cysts seen in treatment groups. Conclusion: Treatment with EEBL is effectively attenuated to the DHEA induced PCOS and it is significant in comparison results with clomiphene citrate attributing its therapeutic potential towards the treatment of PCOS. (IST), JNTUH. He has 4 Patents and many publications over Elsevier, Scopus Journals. He guided many Ph. D Students. His research domains are Anti-diabetic activity of various traditionally used medicinal plants, Evaluation of Immunomodulatory activity of various traditionally used medicinal plants, Isolation of bioactive phytochemical agents, Green synthesis of nanoparticles for development of NDDS.

Background: Gut microbiota can interact with the brain by bidirectional communication through Gut-Brain-Axis. Gut microbiota colonization is essential for the establishment of symbiotic relation between gut and brain. A healthy gut can properly directs the brain for its functions. Autistic people are deficient in gut microbiota, a condition known as Dysbiosis. Gastro-Intestinal symptoms are comorbid conditions in autism. Re-colonization with daily supplementation of microbiota is needed in autism. Methods: Autism induced by Valproic acid (VPA) at a dose of 400 mg/kg, i.p. on an embryonic day (ED) 12 to the pregnant rats. Born rats exhibited many autistic features, for the treatment we selected specific Lactobacilli strains such as L. Plantarum, L. Casei, L. Acidophilus, L. Bulgaricus, with a dosage of not less than (NLT) 1 Billion Colony-forming units (CFU) /ml given orally every day for 42 days. Results: The results showed that Lactobacillus strains significant ameliorated the behavioral anomalies such as T-Maze, Memory, Social interaction studies as compared to the autistic group. Furthermore, Lactobacillus supplementation helped to shift the hypersertonomia (27.33±2.33 vs 8.167±0.72), increasesd BDNF (59.00±2.08 vs 48.17±0.60) increased IL-6 (46.00±1.52 vs 32.00±1.73) and TNFα levels (145.0±3.21 vs 98.67 ± 2.028) to baseline. Histopathology examination of the cerebellum revealed that apoptosis and degeneration were reversed with lactobacillus treatment. Conclusion: This study proved, daily supplementation of Lactobacillus strains has reversed autistic deficits and improved immune functions might because of gut and brain symbiotic relationship.

Objective: The present study was aimed to determine the therapeutic role of resveratrol and pterostilbene alone and combination in reversing the behavioral, biochemical, and histopathological alterations in valproic acid (VPA) induced oxidative stress and neuron damage in a postnatal model of autism. Method: 13 days old Swiss albino mice pups were randomly divided into five groups of six each, vehicle-treated group (1 mg/mL CMC), autistic group (VPA 400 mg/kg, sc), resveratrol (20 mg/kg, po), pterostilbene (10 mg/kg, po), and combination of resveratrol (10 mg/kg, po) + pterostilbene (5 mg/kg, po) group. On postnatal day (PND) 14, valproic acid (VPA) 400 mg/kg, sc, was administered to all except vehicle treated group. Resveratrol and/or pterostilbene was administered daily from PND 14 to 40. During the treatment, period various behavioural parameters were analysed. At the end of study, animals were sacrificed for biochemical estimations and histopathological study. Results: Single time administration of VPA at 400 mg/kg, sc, effectively induced autism. Treatment with resveratrol, pterostilbene, and the combination gave significant recovery in behavioral activity, biochemical, and histopathological alterations in mice when compared with the autistic group. Conclusion: Resveratrol and pterostilbene are good nutraceuticals in reversing the valproic acid-induced autistic deficits, in this study combination of resveratrol and pterostilbene provide superior results on recovery over individual therapy, it is suggested that this combination therapy potentiates the benefits and is more suitable for autism therapy.

The present research work is aimed to investigate the anti-oxidant/neuroprotective role of Resveratrol in reversing the valproic acid induced autism in postnatal swiss albino mice. Separate 13 day old/ Post natal day (PND) 13 swiss albino mice of either sex into 5 groups, each group consists of six mice of either sex, groups namely Group I - Control, Group II - Resveratrol, Group III - Negative control, Group IV and V - Resveratrol treatment groups. On PND 14 administer single dose of Valproic acid (VPA) or Sodium Valproate (400 mg/kg, subcutaneously) to III, IV and V groups to induce autism. Treatment is given in two doses 10 mg/kg, intraperitoneally (i.p) as Low dose and 40 mg/kg, i.p as High dose from the 13th day to the end of study. Assessment of autism is done by different behavioral screening methods during PND 14 to 40. Treatment with resveratrol significantly decline the autism symptoms compared with negative control. At the end of study on PND 41 all the animals were sacrificed to assess the biochemical estimations like Anticholinesterase enzyme, Total Protein, antioxidant enzyme (Catalase, Superoxide and Glutathione) activity and cerebellar histopathological examination. Treatment with Resveratrol has shown a significant beneficial difference on behavioral alterations, oxidative markers, neurotransmitters, and restoration of the altered purkinje cells of autism. This research work we conclude that resvertrol have a potent anti-oxidant, neuroprotective, anxiolytic, learning and memory enhancing agent against valproic acid induced autism.

Abstract:In the present work, an attempt has been made to develop fast disintegrating tablets of Selegiline, were as sodium starch glycolate, cross povidone and cross carmellose sodium were employed as super disintegrating agents to enhance the solubility and dissolution rate of drug molecule. Formulations were prepared by direct compression method using 6mm punch on 8 station rotary tablet punching machine. The blend of all the formulations showed good flow properties such as angle of repose, bulk density and tapped density. The prepared tablets have shown good post compression parameters and they passed all the quality control evaluation parameters as per IP limits. Among all the formulations F2 formulation showed maximum percentage drug release i.e., 97.26 % in 45 min, hence it is considered as optimized formulation. The F2 formulation contains SSG as super disintegrate in the concentration of 24mg.